Corporate Partners

Penn bioengineers are not only changing our knowledge of basic science, but they are bringing new tools and discoveries into practice to improve patient care.  Below is a list of BE faculty who are partnering with industry to bring new technology and treatments from the laboratory to the patient.  New ventures are being explored by BE faculty on a continuing basis.     

Faculty Member Company Research/Technology
Jason Burdick

Penn Spin-off Company (Unnamed)

New treatments for congestive heart failure

Russell J. Composto

Coulter commercialization grant for vascular graft material held jointly with Drexel

Longer lasting grafts for coronary artery bypass and lower limb ischemia

Scott Diamond

Reaction Biology

Tools for nanoscale high throughput drug screening

Paul Ducheyne

OrthoVita and Gentis

Orthopedic implants and tissue engineering

Paul A. Janmey

Critical Biologics

New biologic for treating toxic shock

Brian Litt

NeuroPace; MC10

Implantable tools and computer algorithms for predicting epileptic seizures and sudden cardiac death

Corporations seeking partnerships with our faculty researchers should visit the Penn Engineering website.